Respiratory distress in neonates can be caused by pulmonary issues like respiratory distress syndrome, pneumonia, or transient tachypnea of the newborn, or non-pulmonary issues like cardiac problems, hypoglycemia, or central nervous system conditions. Early recognition and prompt treatment is essential to improve outcomes. Respiratory distress is characterized by tachypnea, chest retractions, and/or grunting. Causes and management should be considered based on gestational age, time of onset, and associated clinical features.
This document discusses various causes of respiratory distress in newborns, including transient tachypnea of the newborn (TTN), respiratory distress syndrome (RDS), and neonatal pneumonia. It provides details on the signs and symptoms, risk factors, diagnosis, and management of each condition. For TTN, it notes the risk factors include premature birth or c-section without labor. For RDS, it explains that surfactant deficiency in preterm infants is the primary cause. For neonatal pneumonia, it identifies the most common causative organisms and states diagnosis is based on clinical, radiographic, and microbiological findings.
Bronchopulmonary dysplasia (BPD) is a lung disease that primarily affects extremely premature infants. The most severe cases occur in babies born between 23-26 weeks gestation. While corticosteroids and diuretics can provide short-term improvement for ventilator-dependent infants, there are safety concerns about steroid use. When transitioning infants with BPD from the neonatal intensive care unit to other facilities, it can be difficult for parents to adjust to new practices and staff. Oxygen management also varies, as there is no consensus on optimal weaning.
The document discusses shock in children, defining it as circulatory system failure to supply oxygen and nutrients to meet cellular demands. It covers circulatory physiology, classifications of shock, evaluation, treatment including fluid resuscitation and vasoactive drugs, and specific types of shock such as hypovolemic, cardiogenic, obstructive, and distributive shock. Metabolic issues associated with shock like acid-base and electrolyte abnormalities are also reviewed.
Apnea of prematurity is the most common respiratory problem in premature infants, prolonging hospitalization. It is defined as a cessation of breathing for 20 seconds or less if accompanied by bradycardia or cyanosis. Incidence and severity are inversely related to gestational age, with 50% of infants under 1500g requiring intervention. Proposed causes include immaturity of the respiratory center, decreased afferent input, abnormal reflexes, and hypoxemia. Treatment focuses on stimulation, treating underlying causes, methylxanthines to stimulate breathing, and CPAP for severe or refractory cases. Methylxanthines like caffeine are the first line treatment but CPAP may be used if apnea is not resolved
Neonatal acute respiratory distress syndrome (RDS) is caused by surfactant deficiency in premature infants. Surfactant is produced in the lungs beginning at 24 weeks gestation and helps lower surface tension to prevent alveolar collapse. Preemies are at risk for RDS due to incomplete lung development and surfactant production. Treatment includes supportive care like CPAP, surfactant replacement therapy, and mechanical ventilation if needed. With treatment and lung maturation, symptoms typically improve within 3-5 days.
This document discusses common respiratory problems in newborns including signs of respiratory distress. It outlines various pulmonary and extra-pulmonary causes of neonatal respiratory distress such as respiratory distress syndrome, transient tachypnea of the newborn, pneumonia, meconium aspiration and conditions affecting the pediatric respiratory system. Evaluation and management of respiratory distress as well as specific conditions like bronchopulmonary dysplasia are described.
This document discusses empyema, a type of pleural infection. It begins by outlining the aims and introduction. It then covers the pathogenesis and types of paraneumonic pleural effusions. Diagnosis involves thoracentesis and pleural fluid analysis. Common causative bacteria include streptococcus, staphylococcus aureus, and anaerobes. Treatment requires accurate diagnosis, appropriate antibiotic therapy guided by cultures, drainage of infected material via chest tube, and potential intrapleural therapies. Complications can arise if not properly treated.
This document discusses various causes of respiratory distress in newborns, including transient tachypnea of the newborn (TTN), respiratory distress syndrome (RDS), and neonatal pneumonia. It provides details on the signs and symptoms, risk factors, diagnosis, and management of each condition. For TTN, it notes the risk factors include premature birth or c-section without labor. For RDS, it explains that surfactant deficiency in preterm infants is the primary cause. For neonatal pneumonia, it identifies the most common causative organisms and states diagnosis is based on clinical, radiographic, and microbiological findings.
Bronchopulmonary dysplasia (BPD) is a lung disease that primarily affects extremely premature infants. The most severe cases occur in babies born between 23-26 weeks gestation. While corticosteroids and diuretics can provide short-term improvement for ventilator-dependent infants, there are safety concerns about steroid use. When transitioning infants with BPD from the neonatal intensive care unit to other facilities, it can be difficult for parents to adjust to new practices and staff. Oxygen management also varies, as there is no consensus on optimal weaning.
The document discusses shock in children, defining it as circulatory system failure to supply oxygen and nutrients to meet cellular demands. It covers circulatory physiology, classifications of shock, evaluation, treatment including fluid resuscitation and vasoactive drugs, and specific types of shock such as hypovolemic, cardiogenic, obstructive, and distributive shock. Metabolic issues associated with shock like acid-base and electrolyte abnormalities are also reviewed.
Apnea of prematurity is the most common respiratory problem in premature infants, prolonging hospitalization. It is defined as a cessation of breathing for 20 seconds or less if accompanied by bradycardia or cyanosis. Incidence and severity are inversely related to gestational age, with 50% of infants under 1500g requiring intervention. Proposed causes include immaturity of the respiratory center, decreased afferent input, abnormal reflexes, and hypoxemia. Treatment focuses on stimulation, treating underlying causes, methylxanthines to stimulate breathing, and CPAP for severe or refractory cases. Methylxanthines like caffeine are the first line treatment but CPAP may be used if apnea is not resolved
Neonatal acute respiratory distress syndrome (RDS) is caused by surfactant deficiency in premature infants. Surfactant is produced in the lungs beginning at 24 weeks gestation and helps lower surface tension to prevent alveolar collapse. Preemies are at risk for RDS due to incomplete lung development and surfactant production. Treatment includes supportive care like CPAP, surfactant replacement therapy, and mechanical ventilation if needed. With treatment and lung maturation, symptoms typically improve within 3-5 days.
This document discusses common respiratory problems in newborns including signs of respiratory distress. It outlines various pulmonary and extra-pulmonary causes of neonatal respiratory distress such as respiratory distress syndrome, transient tachypnea of the newborn, pneumonia, meconium aspiration and conditions affecting the pediatric respiratory system. Evaluation and management of respiratory distress as well as specific conditions like bronchopulmonary dysplasia are described.
This document discusses empyema, a type of pleural infection. It begins by outlining the aims and introduction. It then covers the pathogenesis and types of paraneumonic pleural effusions. Diagnosis involves thoracentesis and pleural fluid analysis. Common causative bacteria include streptococcus, staphylococcus aureus, and anaerobes. Treatment requires accurate diagnosis, appropriate antibiotic therapy guided by cultures, drainage of infected material via chest tube, and potential intrapleural therapies. Complications can arise if not properly treated.
Apnea of prematurity (AOP) is a condition where premature infants stop breathing for 15-20 seconds during sleep, most often in infants born at 35 weeks gestation or less. When they stop breathing, their heart rate drops below 80 beats per minute and they may appear limp or blue in color. AOP is treated through monitoring breathing and heart rate, medications to stimulate breathing, or in severe cases ventilation support. It typically resolves by 44 weeks postconceptional age.
A preterm newborn developed respiratory distress soon after birth, with signs including grunting and cyanosis. Evaluation found respiratory distress syndrome (RDS). The baby was treated with nasal CPAP, surfactant, and mechanical ventilation. RDS is caused by surfactant deficiency in premature infants, resulting in alveolar collapse and impaired gas exchange. Management includes respiratory support, surfactant replacement therapy, and care to prevent complications.
This document discusses exogenous surfactant therapy for preterm infants. It provides guidelines on its use, including:
- Natural surfactants are preferred over synthetic versions.
- Prophylactic use within 15 minutes of life or rescue therapy improves outcomes like mortality and pneumothoraces.
- Multiple doses may be more beneficial than a single dose due to transient response and functional inactivation.
- Combining antenatal steroids and postnatal surfactant therapy has synergistic benefits and reduces mortality and morbidity.
This document discusses bronchopulmonary dysplasia (BPD), a chronic lung disease that occurs in premature infants requiring respiratory support. It covers the definition, risk factors, pathogenesis, clinical features, prevention, and treatment of BPD. The definition has evolved over time from relying solely on oxygen need at 28 days to incorporating factors like oxygen need, pressure support, and gestational age. BPD results from lung injury and disrupted lung development due to prematurity and respiratory support. Management aims to protect the lung from injury through gentle ventilation, optimal oxygen levels, and other strategies.
A powerpoint presentation on the respiratory illness seen in newborns/neonates.
the diseases mentioned in this presentation are among the most commonly seen in the population.
This document discusses neonatal thrombocytopenia. It defines thrombocytopenia in neonates as a platelet count below 150,000/mcL. The incidence is 0.7-0.9% overall but higher in NICUs at 22-35%. Causes include fetal alloimmune conditions, infections, genetic disorders, placental insufficiency, and perinatal complications. Evaluation and management depends on timing of onset (early vs late) and severity (mild, moderate, severe). Testing may include antigen screening for conditions like NAIT. Treatment involves treating any underlying conditions, IVIG, and platelet transfusions following guidelines based on platelet count and clinical status.
This document provides information on the clinical presentation and management of respiratory distress in newborns. It discusses the most common causes including transient tachypnea of the newborn, respiratory distress syndrome, and meconium aspiration syndrome. For each condition, it describes the typical symptoms, risk factors, diagnostic findings, and treatment approaches. The differential diagnosis section outlines other less common conditions that can cause respiratory distress in newborns.
Respiratory distress is a common problem in newborns that can have various causes. It requires early recognition and treatment to prevent morbidity and mortality. The document discusses the causes, clinical presentation, diagnostic evaluation and management of respiratory distress in newborns. Evaluation involves detailed history, physical exam including assessment of respiratory rate, retractions, grunting and cyanosis. Investigations may include chest x-ray, blood gas analysis and sepsis workup. Management is supportive with oxygen therapy, fluid resuscitation and respiratory support as needed. Specific treatments target the underlying condition.
The document discusses respiratory distress in neonates. It describes the clinical presentation of respiratory distress and various scoring systems used to assess severity. It then covers the major causes of respiratory distress including transient tachypnea of the newborn, respiratory distress syndrome, meconium aspiration syndrome, pneumonia and others. For each cause, it discusses risk factors, clinical features, investigations and management. The management sections provide details on oxygen therapy, CPAP, surfactant administration and mechanical ventilation.
Surfactant replacement therapy : RDS & beyondDr-Hasen Mia
This presentation is about Surfactant, its use in Respiratory Distress Syndrome & some other conditions of surfactant deficiency due to inactivation like meconium aspiration syndrome & others
This document provides information on chronic cough in children, including definitions, epidemiology, pathophysiology, causes, diagnostic approach, and management. It defines chronic cough as lasting 4 or more weeks based on expert guidelines. Specific cough has an identifiable cause while nonspecific cough does not after evaluation. Common causes include asthma, aspiration, and suppurative lung diseases. The diagnostic approach involves detailed history, physical exam focusing on cough characteristics, chest imaging, and additional tests as needed based on findings. Management targets treating the identified cause for specific cough or watchful waiting for most nonspecific cough cases.
Neonatal apnea is the cessation of breathing for over 10-15 seconds, commonly affecting premature infants around 2-6 months old due to underdeveloped respiratory systems. There are three main types of apnea: central apnea caused by lack of breathing signal from the brain; obstructive apnea caused by weak respiratory muscles; and mixed apnea showing traits of both. Treatment of neonatal apnea in preterm infants involves close monitoring in the NICU, determining underlying causes, and administering medication depending on severity and type of apnea.
Pulmonary Hypertension of the Newborn - all you need to knowSid Kaithakkoden
Persistent pulmonary hypertension of the newborn (PPHN) is the failure of the pulmonary vascular resistance to decrease after birth, resulting in right-to-left shunting of blood and hypoxemia. It can be primary or secondary to conditions like meconium aspiration syndrome, asphyxia, or lung hypoplasia. Diagnosis involves signs of cyanosis and hypoxemia unresponsive to oxygen. Treatment aims to maintain oxygenation through supportive care, vasodilator drugs like inhaled nitric oxide, high frequency ventilation, and in severe cases, extracorporeal membrane oxygenation.
Respiratory distress is a common problem in newborns. This document discusses the epidemiology, clinical features, assessment, causes and management approaches for several major causes of respiratory distress in newborns, including meconium aspiration syndrome, respiratory distress syndrome, and transient tachypnea of newborn. It provides clinical guidance on evaluating and treating newborns presenting with respiratory distress.
Neonatal resuscitation is an intervention performed on babies after birth to help them breathe and for their heart to beat properly. It is needed for about 10% of babies who have trouble transitioning from receiving oxygen from the placenta to breathing on their own. Proper neonatal resuscitation training and equipment can reduce infant mortality from complications during birth by 30%.
Meconium aspiration syndrome occurs when meconium, the first intestinal discharge of a newborn, is aspirated into the lungs. This can happen when the fetus experiences distress in utero and gasps or takes deep breaths. Meconium aspiration syndrome causes airway obstruction, inflammation, surfactant dysfunction, and can lead to pulmonary hypertension. Treatment involves ventilation support, steroids, antibiotics, surfactant replacement, and potentially ECMO. One study found that administering surfactant to infants under 6 hours old with meconium aspiration syndrome significantly reduced their need for ECMO, time on ventilation, oxygen use, and hospital stay compared to controls.
Persistent pulmonary hypertension of the newborn (PPHN) is a major problem in neonatal intensive care units that can lead to death or neurological injury in newborns. It occurs when the pulmonary circulation fails to transition from the high resistance fetal state. Causes include meconium aspiration syndrome, idiopathic PPHN, and pulmonary hypoplasia from conditions like congenital diaphragmatic hernia. Treatment involves optimizing oxygenation and cardiac function along with pulmonary vasodilators like inhaled nitric oxide. Future therapies may include phosphodiesterase inhibitors and prostacyclin analogs to further reduce pulmonary hypertension in newborns.
Anaphylaxis is a serious allergic reaction that is rapid in onset and may cause death. Common triggers include foods, medications, insect stings, latex, and exercise. Symptoms involve multiple organ systems and include skin issues like hives, respiratory problems, gastrointestinal distress, cardiovascular or neurological issues. Diagnosis is based on acute onset of symptoms after exposure to a known or suspected allergen. Treatment involves supporting airway, breathing, and circulation. Epinephrine is given intramuscularly as first line treatment along with antihistamines and corticosteroids. Close monitoring is required and additional epinephrine or other vasopressors may be needed if hypotension persists.
This document discusses persistent pulmonary hypertension of the newborn (PPHN). It defines PPHN as failure of the normal circulatory transition at birth, causing elevated pulmonary vascular resistance and decreased pulmonary blood flow. The document covers the incidence, etiology, pathophysiology, diagnosis and management of PPHN. Key aspects of management include supportive care, gentle mechanical ventilation, use of inhaled nitric oxide and high-frequency oscillatory ventilation in severe cases.
This document discusses the medical and surgical causes of respiratory distress in newborns and the approach to evaluation and management. Common medical causes include transient tachypnea of the newborn, respiratory distress syndrome, and pneumonia/sepsis. Surgical causes include pneumothorax, diaphragmatic hernia, and tracheoesophageal fistula. The document provides details on evaluating key factors such as gestation, weight, and onset of symptoms. It also describes clinical features and investigations to identify the specific condition causing respiratory distress and outlines management approaches for various surgical conditions.
The document discusses infant respiratory distress syndrome (IRDS), a condition in premature infants caused by a lack of surfactant in the lungs. Some key points: IRDS occurs most often in preterm babies less than 28 weeks gestation. It causes breathing difficulties due to a lack of surfactant, which keeps alveoli open. Symptoms include respiratory distress and cyanosis. Diagnosis involves chest X-ray and blood gas analysis. Treatment requires oxygen, fluids, ventilation support if needed, and administration of surfactant to premature infants. With proper treatment survival rates are high, though complications can include bronchopulmonary dysplasia.
Apnea of prematurity (AOP) is a condition where premature infants stop breathing for 15-20 seconds during sleep, most often in infants born at 35 weeks gestation or less. When they stop breathing, their heart rate drops below 80 beats per minute and they may appear limp or blue in color. AOP is treated through monitoring breathing and heart rate, medications to stimulate breathing, or in severe cases ventilation support. It typically resolves by 44 weeks postconceptional age.
A preterm newborn developed respiratory distress soon after birth, with signs including grunting and cyanosis. Evaluation found respiratory distress syndrome (RDS). The baby was treated with nasal CPAP, surfactant, and mechanical ventilation. RDS is caused by surfactant deficiency in premature infants, resulting in alveolar collapse and impaired gas exchange. Management includes respiratory support, surfactant replacement therapy, and care to prevent complications.
This document discusses exogenous surfactant therapy for preterm infants. It provides guidelines on its use, including:
- Natural surfactants are preferred over synthetic versions.
- Prophylactic use within 15 minutes of life or rescue therapy improves outcomes like mortality and pneumothoraces.
- Multiple doses may be more beneficial than a single dose due to transient response and functional inactivation.
- Combining antenatal steroids and postnatal surfactant therapy has synergistic benefits and reduces mortality and morbidity.
This document discusses bronchopulmonary dysplasia (BPD), a chronic lung disease that occurs in premature infants requiring respiratory support. It covers the definition, risk factors, pathogenesis, clinical features, prevention, and treatment of BPD. The definition has evolved over time from relying solely on oxygen need at 28 days to incorporating factors like oxygen need, pressure support, and gestational age. BPD results from lung injury and disrupted lung development due to prematurity and respiratory support. Management aims to protect the lung from injury through gentle ventilation, optimal oxygen levels, and other strategies.
A powerpoint presentation on the respiratory illness seen in newborns/neonates.
the diseases mentioned in this presentation are among the most commonly seen in the population.
This document discusses neonatal thrombocytopenia. It defines thrombocytopenia in neonates as a platelet count below 150,000/mcL. The incidence is 0.7-0.9% overall but higher in NICUs at 22-35%. Causes include fetal alloimmune conditions, infections, genetic disorders, placental insufficiency, and perinatal complications. Evaluation and management depends on timing of onset (early vs late) and severity (mild, moderate, severe). Testing may include antigen screening for conditions like NAIT. Treatment involves treating any underlying conditions, IVIG, and platelet transfusions following guidelines based on platelet count and clinical status.
This document provides information on the clinical presentation and management of respiratory distress in newborns. It discusses the most common causes including transient tachypnea of the newborn, respiratory distress syndrome, and meconium aspiration syndrome. For each condition, it describes the typical symptoms, risk factors, diagnostic findings, and treatment approaches. The differential diagnosis section outlines other less common conditions that can cause respiratory distress in newborns.
Respiratory distress is a common problem in newborns that can have various causes. It requires early recognition and treatment to prevent morbidity and mortality. The document discusses the causes, clinical presentation, diagnostic evaluation and management of respiratory distress in newborns. Evaluation involves detailed history, physical exam including assessment of respiratory rate, retractions, grunting and cyanosis. Investigations may include chest x-ray, blood gas analysis and sepsis workup. Management is supportive with oxygen therapy, fluid resuscitation and respiratory support as needed. Specific treatments target the underlying condition.
The document discusses respiratory distress in neonates. It describes the clinical presentation of respiratory distress and various scoring systems used to assess severity. It then covers the major causes of respiratory distress including transient tachypnea of the newborn, respiratory distress syndrome, meconium aspiration syndrome, pneumonia and others. For each cause, it discusses risk factors, clinical features, investigations and management. The management sections provide details on oxygen therapy, CPAP, surfactant administration and mechanical ventilation.
Surfactant replacement therapy : RDS & beyondDr-Hasen Mia
This presentation is about Surfactant, its use in Respiratory Distress Syndrome & some other conditions of surfactant deficiency due to inactivation like meconium aspiration syndrome & others
This document provides information on chronic cough in children, including definitions, epidemiology, pathophysiology, causes, diagnostic approach, and management. It defines chronic cough as lasting 4 or more weeks based on expert guidelines. Specific cough has an identifiable cause while nonspecific cough does not after evaluation. Common causes include asthma, aspiration, and suppurative lung diseases. The diagnostic approach involves detailed history, physical exam focusing on cough characteristics, chest imaging, and additional tests as needed based on findings. Management targets treating the identified cause for specific cough or watchful waiting for most nonspecific cough cases.
Neonatal apnea is the cessation of breathing for over 10-15 seconds, commonly affecting premature infants around 2-6 months old due to underdeveloped respiratory systems. There are three main types of apnea: central apnea caused by lack of breathing signal from the brain; obstructive apnea caused by weak respiratory muscles; and mixed apnea showing traits of both. Treatment of neonatal apnea in preterm infants involves close monitoring in the NICU, determining underlying causes, and administering medication depending on severity and type of apnea.
Pulmonary Hypertension of the Newborn - all you need to knowSid Kaithakkoden
Persistent pulmonary hypertension of the newborn (PPHN) is the failure of the pulmonary vascular resistance to decrease after birth, resulting in right-to-left shunting of blood and hypoxemia. It can be primary or secondary to conditions like meconium aspiration syndrome, asphyxia, or lung hypoplasia. Diagnosis involves signs of cyanosis and hypoxemia unresponsive to oxygen. Treatment aims to maintain oxygenation through supportive care, vasodilator drugs like inhaled nitric oxide, high frequency ventilation, and in severe cases, extracorporeal membrane oxygenation.
Respiratory distress is a common problem in newborns. This document discusses the epidemiology, clinical features, assessment, causes and management approaches for several major causes of respiratory distress in newborns, including meconium aspiration syndrome, respiratory distress syndrome, and transient tachypnea of newborn. It provides clinical guidance on evaluating and treating newborns presenting with respiratory distress.
Neonatal resuscitation is an intervention performed on babies after birth to help them breathe and for their heart to beat properly. It is needed for about 10% of babies who have trouble transitioning from receiving oxygen from the placenta to breathing on their own. Proper neonatal resuscitation training and equipment can reduce infant mortality from complications during birth by 30%.
Meconium aspiration syndrome occurs when meconium, the first intestinal discharge of a newborn, is aspirated into the lungs. This can happen when the fetus experiences distress in utero and gasps or takes deep breaths. Meconium aspiration syndrome causes airway obstruction, inflammation, surfactant dysfunction, and can lead to pulmonary hypertension. Treatment involves ventilation support, steroids, antibiotics, surfactant replacement, and potentially ECMO. One study found that administering surfactant to infants under 6 hours old with meconium aspiration syndrome significantly reduced their need for ECMO, time on ventilation, oxygen use, and hospital stay compared to controls.
Persistent pulmonary hypertension of the newborn (PPHN) is a major problem in neonatal intensive care units that can lead to death or neurological injury in newborns. It occurs when the pulmonary circulation fails to transition from the high resistance fetal state. Causes include meconium aspiration syndrome, idiopathic PPHN, and pulmonary hypoplasia from conditions like congenital diaphragmatic hernia. Treatment involves optimizing oxygenation and cardiac function along with pulmonary vasodilators like inhaled nitric oxide. Future therapies may include phosphodiesterase inhibitors and prostacyclin analogs to further reduce pulmonary hypertension in newborns.
Anaphylaxis is a serious allergic reaction that is rapid in onset and may cause death. Common triggers include foods, medications, insect stings, latex, and exercise. Symptoms involve multiple organ systems and include skin issues like hives, respiratory problems, gastrointestinal distress, cardiovascular or neurological issues. Diagnosis is based on acute onset of symptoms after exposure to a known or suspected allergen. Treatment involves supporting airway, breathing, and circulation. Epinephrine is given intramuscularly as first line treatment along with antihistamines and corticosteroids. Close monitoring is required and additional epinephrine or other vasopressors may be needed if hypotension persists.
This document discusses persistent pulmonary hypertension of the newborn (PPHN). It defines PPHN as failure of the normal circulatory transition at birth, causing elevated pulmonary vascular resistance and decreased pulmonary blood flow. The document covers the incidence, etiology, pathophysiology, diagnosis and management of PPHN. Key aspects of management include supportive care, gentle mechanical ventilation, use of inhaled nitric oxide and high-frequency oscillatory ventilation in severe cases.
This document discusses the medical and surgical causes of respiratory distress in newborns and the approach to evaluation and management. Common medical causes include transient tachypnea of the newborn, respiratory distress syndrome, and pneumonia/sepsis. Surgical causes include pneumothorax, diaphragmatic hernia, and tracheoesophageal fistula. The document provides details on evaluating key factors such as gestation, weight, and onset of symptoms. It also describes clinical features and investigations to identify the specific condition causing respiratory distress and outlines management approaches for various surgical conditions.
The document discusses infant respiratory distress syndrome (IRDS), a condition in premature infants caused by a lack of surfactant in the lungs. Some key points: IRDS occurs most often in preterm babies less than 28 weeks gestation. It causes breathing difficulties due to a lack of surfactant, which keeps alveoli open. Symptoms include respiratory distress and cyanosis. Diagnosis involves chest X-ray and blood gas analysis. Treatment requires oxygen, fluids, ventilation support if needed, and administration of surfactant to premature infants. With proper treatment survival rates are high, though complications can include bronchopulmonary dysplasia.
This document discusses several common respiratory diseases that can affect newborns, including respiratory distress syndrome (RDS), transient tachypnea of the newborn (TTN), meconium aspiration syndrome (MAS), primary pulmonary hypertension of the newborn (PPHN), and apnea of prematurity. It provides details on the causes, clinical presentations, diagnoses and management of each condition. The document is intended to educate medical professionals such as pediatricians on recognizing and treating respiratory issues in newborns.
This document discusses neonatal respiratory distress, including signs, symptoms, and common etiologies. The main pulmonary causes discussed are transient tachypnea of newborn, respiratory distress syndrome, meconium aspiration syndrome, pneumonia, and air leak syndromes. For each cause, risk factors, pathophysiology, clinical manifestations, diagnostic findings, and management approaches are summarized. The document provides an overview of evaluation and treatment of neonatal respiratory distress.
This document discusses apnea of prematurity (AOP), which refers to cessation of breathing seen in premature infants due to immaturity of respiratory control systems. AOP is defined as absent breathing accompanied by bradycardia and desaturation. The risk is highest in infants born before 28 weeks gestation, with over 60% affected. Treatment involves identifying/treating underlying causes, caffeine therapy to increase breathing drive, and respiratory support like CPAP if needed. AOP generally resolves by 37 weeks but can persist longer in more premature infants. Prompt treatment is important to avoid hypoxia-related risks.
Respiratory distress in neonates can be identified by tachypnea, chest indrawing, and other signs. It can be caused by pulmonary issues like respiratory distress syndrome, meconium aspiration syndrome, or transient tachypnea of the newborn. Non-pulmonary causes include perinatal asphyxia, hypothermia, and congenital heart disease. Transient tachypnea of the newborn involves defective sodium transport leading to retained lung fluid and is often seen in babies delivered by c-section. It typically resolves within a few days with supportive care like oxygen and feeding assistance. Persistent pulmonary hypertension of the newborn results when normal postnatal pulmonary pressure reduction fails and presents a serious
Respiratory Distress Syndrome by DR FAITHFUL DANIEL.pptxDanielFaithful
Respiratory Distress Sydrome is a condition that affects the lungs of newborn infants predominantly. Not much is known about the condition in the tropics.
In this presentation Daniel Faithful Miebaka provides detailed review of the condition that has fatal potential.
Neonatal respiratory diseases can present as respiratory distress in newborns, characterized by tachypnea, grunting, chest wall indrawing, and cyanosis. Common causes include respiratory distress syndrome (lack of surfactant), pneumonia, meconium aspiration syndrome, and congenital diaphragmatic hernia. Respiratory distress syndrome is treated with supportive care like oxygen supplementation or CPAP, and may require mechanical ventilation. Pneumonia is usually treated with antibiotics and oxygen as needed. Meconium aspiration syndrome can cause lung injury and inflammation requiring oxygen, antibiotics, and steroids. Congenital diaphragmatic hernia presents with respiratory distress at birth due to lung compression, and is
This document provides an outline and overview of respiratory distress in newborns. It discusses the common features, causes, diagnostic approach, and management of respiratory distress. The main causes covered are transient tachypnea of the newborn (TTN), respiratory distress syndrome (RDS), meconium aspiration syndrome (MAS), pneumonia/neonatal sepsis, and congenital anomalies. For each cause, it discusses epidemiology, pathophysiology, clinical presentation, diagnostic tools such as chest x-ray findings, and treatment approaches. The document emphasizes the importance of a thorough history and physical exam in evaluating the cause of respiratory distress in newborns.
The document discusses the case of a preterm newborn male infant born at 29 weeks gestation with a birth weight of 920g who presented with respiratory distress soon after birth and was admitted to the NICU. The document outlines the infant's history, examination findings, and proposes evaluating the cause of respiratory distress and developing a treatment plan. Differential diagnoses and management strategies for respiratory distress in preterm newborns are also reviewed.
This document discusses respiratory distress and respiratory distress syndrome in neonates. It defines respiratory distress and describes the clinical signs. Various pulmonary and non-pulmonary causes are outlined. Respiratory distress syndrome, also known as hyaline membrane disease, is described in detail, including risk factors, pathophysiology, clinical presentation, investigations, complications, prevention, and treatment approaches like surfactant administration and nasal continuous positive airway pressure. The prognosis depends on gestational age and quality of care provided.
This document discusses apnea of prematurity, defined as the cessation of breathing for over 20 seconds or less than 20 seconds accompanied by hypoxia or bradycardia in premature infants. It classifies apnea as central, obstructive, or mixed. Risk increases inversely with gestational age. Causes include immaturity of the brainstem respiratory center and exaggerated laryngeal reflex. Clinical presentation involves monitoring for apnea, bradycardia, and desaturation. Diagnosis is made using cardiorespiratory monitoring and pulse oximetry.
respiratory difficulty commonly in a preterm neonate and is due to deficiency of pulmonary surfactant. It was formerly known as Hyaline Membrane Disease (HMD).
presented by Dr. Taher
Respiratory distress is common in preterm infants and can have serious consequences. It is defined as the presence of tachypnea, retractions, or grunting. Common causes include respiratory distress syndrome (RDS) due to surfactant deficiency. Assessment involves evaluating respiratory rate, work of breathing, oxygen needs and chest x-ray findings. Management consists of supportive care including oxygen supplementation, monitoring, antibiotics if indicated. Surfactant replacement therapy improves outcomes in RDS but can increase risk of apnea. Non-invasive respiratory support with CPAP is preferred over mechanical ventilation when possible.
complications in newborn pediatrics 3.pptArun170190
This document provides information on transient tachypnea of the newborn (TTN), including:
- TTN is a temporary respiratory condition where newborns have difficulty clearing fluid from their lungs after birth, causing fast breathing.
- Risk factors include cesarean delivery without labor. Symptoms include fast breathing and grunting. Chest X-rays can help with diagnosis.
- Treatment focuses on supportive care like oxygen supplementation. TTN typically resolves within 3 days without long-term impacts. While common, it can occasionally require interventions like CPAP. Overall, TTN prognosis is excellent in most newborns.
This document discusses respiratory distress in neonates, focusing on respiratory distress syndrome (RDS). It describes the signs, risk factors, pathophysiology, diagnosis, and management of RDS. Surfactant deficiency is the primary cause of RDS. Treatment involves oxygen, CPAP, mechanical ventilation if needed, and surfactant replacement therapy. With advances in care including antenatal steroids and surfactant replacement therapy, mortality from RDS has decreased.
This document discusses clinical manifestations and evaluation of renal disease in children. Common signs of renal disorders include edema, hematuria, abnormalities in urination, and flank or abdominal pain. Evaluation of renal disease involves examination of urine for red blood cells, proteins, and casts. Imaging tests like ultrasound and IVU can identify structural abnormalities. Glomerular diseases commonly cause hematuria while tubular disorders present with electrolyte abnormalities. Renal biopsy may be needed to diagnose conditions like Alport syndrome.
This document summarizes common viral infections including measles, varicella, mumps, and viral hepatitis. Measles is caused by a paramyxovirus and causes a rash and respiratory symptoms. Varicella (chickenpox) is caused by varicella zoster virus and presents with a pruritic vesicular rash that spreads. Mumps is caused by a paramyxovirus and presents with painful swelling of the salivary glands. Hepatitis A and B viruses are described as common causes of viral hepatitis transmitted through fecal-oral and blood-borne routes respectively.
Principles of acute management of diabetic ketoacidosisEric General
This document provides guidelines for managing diabetic ketoacidosis (DKA) in children. It outlines recommendations for initial fluid bolus and hydration, monitoring of electrolytes and glucose during treatment, use of bicarbonate and insulin therapy, and monitoring of vital signs and lab values. It also describes cerebral edema as a potential complication of DKA and recommends reducing fluid administration rates and using mannitol or hypertonic saline if cerebral edema develops.
This document discusses pediatric anemia. It defines anemia based on hemoglobin and hematocrit levels below certain thresholds defined by age and sex. Anemia results in physiological adaptations like increased cardiac output to maintain oxygen delivery to tissues. Causes of anemia vary by age and can be multifactorial, including nutritional deficiencies, blood loss, infections, and genetic disorders. Iron deficiency is a common cause, presenting with microcytic indices and low iron studies. Evaluation involves a complete blood count and smear to classify anemia, along with testing to identify the underlying cause.
Congenital heart disease (CHD) refers to structural heart defects present at birth. Diagnosis involves history, physical exam, chest X-ray, ECG, and echocardiogram. Most CHDs can be corrected with surgery if done in a timely manner. Echocardiography can identify and determine severity of specific lesions. Pediatricians must also identify any associated conditions that could impact outcomes.
This document discusses congestive cardiac failure in infants and children. It describes the causes, signs, and management of cardiac failure. The main causes in infants include congenital heart disease, arrhythmias like supraventricular tachycardia, and myocarditis. Signs of left-sided failure include tachypnea and hepatomegaly while signs of right-sided failure include hepatomegaly and facial edema. Management involves reducing cardiac workload, improving contractility, and treating the underlying cause. Diuretics, vasodilators, inotropes, and drugs that suppress the renin-angiotensin system are used. Prognosis depends on the cause, with mortality from cardiac failure being high
1. Tracheoesophageal fistula occurs due to deviation or altered cellular growth in the septum that separates the respiratory and esophageal primordia during development. It has an incidence of 1 in 4,000 live births.
2. Clinical features include excessive drooling, choking, and cyanosis during feeding as well as aspiration pneumonia from overflow of secretions into the lungs.
3. Diagnosis is made by passing a stiff catheter into the esophagus and obtaining an x-ray, which will show an air bubble in the stomach if there is a communication between the esophagus and trachea.
The document summarizes information about malaria, including that it is caused by Plasmodium parasites and can range from uncomplicated to severe. Severe malaria affects multiple organ systems and has a 20% mortality rate if not properly treated. Diagnosis involves examining thick and thin blood films under a microscope. Treatment depends on the severity of the case, with uncomplicated malaria typically treated with artemisinin-based combination therapy and severe malaria requiring hospitalization and parenteral antimalarial drugs along with supportive therapies.
This document provides information on various types of acyanotic congenital heart defects, including their anatomy, physiology, clinical features, diagnosis, treatment and prognosis. It discusses atrial septal defects (ASD), ventricular septal defects (VSD), and patent ductus arteriosus (PDA). ASDs are classified based on their location. VSDs account for one-quarter of all congenital heart defects and result in left-to-right shunting. PDA causes left-to-right shunting between the aorta and pulmonary artery. Surgical or catheterization closure is often recommended for larger defects.
Neonatal sepsis refers to systemic bacterial infections in newborns. Early-onset sepsis occurs within 72 hours of birth and is usually caused by maternal genital tract organisms. Late-onset sepsis occurs after 72 hours and is often caused by environmental organisms acquired in the hospital or home. Treatment involves supportive care and empiric antibiotics targeting common causes like E. coli, S. aureus, and Klebsiella spp. Prompt treatment is important but overuse of antibiotics risks emerging resistance, so diagnosis is confirmed using blood cultures and sepsis screening tests when possible. Outcomes depend on the infant's health and prompt, appropriate treatment.
This document provides guidance on performing a newborn history and examination. It outlines key components to include in the history such as the mother's obstetric history, antenatal care, labor/delivery details, and newborn's immediate care and current problems. The examination section describes assessing the newborn's appearance, vital signs, measurements, and performing a full physical exam including the neurological exam and evaluating primary reflexes like the Moro reflex. The goal is to obtain a thorough history and perform an examination of all body systems to identify any issues in the newborn.
This document discusses acute kidney injury (AKI), formerly known as acute renal failure, in pediatrics. It defines AKI, describes the causes and pathophysiology, presents approaches to evaluation and management, and outlines treatment of complications. The key points are:
- AKI is defined as an abrupt reduction in kidney function over 48 hours, seen as a rise in creatinine or decrease in urine output.
- Common causes include prerenal failure from hypovolemia, intrinsic renal failure like acute tubular necrosis, and postrenal failure from urinary tract obstruction.
- Management involves treating complications, maintaining fluid/electrolyte balance, and considering dialysis for issues like fluid
This document discusses jaundice in newborns. It describes physiological jaundice as normal and temporary, while pathological jaundice requires treatment. Pathological jaundice is defined as a total serum bilirubin level exceeding certain thresholds depending on the baby's age. Causes of jaundice include hemolytic issues and problems with feeding. Treatment may involve phototherapy or exchange transfusions in severe cases. Monitoring, prevention, and ensuring proper breastfeeding are also discussed.
This document discusses acute lymphoblastic leukemia (ALL) and acute myeloid leukemia (AML). It describes the epidemiology, pathogenesis, classification, clinical presentation, diagnosis, prognostic factors, management and outcomes of both ALL and AML in children. ALL is more common and has a better prognosis than AML. Prognostic factors for ALL include age, white blood cell count, specific genetic mutations and response to initial treatment. Treatment involves induction, consolidation, central nervous system prophylaxis and maintenance therapy over 2-3 years.
This document discusses encephalitis and encephalopathies in pediatrics. Encephalitis involves inflammation of the brain parenchyma, while encephalopathy implies cerebral dysfunction due to toxins or metabolic disorders without inflammation. Etiologies include various viruses, bacteria, fungi, parasites, toxins and metabolic disorders. Clinical manifestations depend on severity, localization, and presence of increased intracranial pressure, and can range from mild illness to severe encephalomyelitis. Diagnosis involves ruling out treatable causes through examinations, tests, and imaging. Management focuses on emergency treatment, controlling seizures and pressure, and treating the underlying cause.
This document discusses cerebral palsy (CP), a nonprogressive neuromotor disorder of cerebral origin. CP can be caused by factors operating prenatally, during delivery, or postnatally. It is classified based on topographic distribution, neurological findings, and etiology, with the main types being spastic, hypotonic, extrapyramidal, and cerebellar CP. Evaluation of patients with CP includes assessing eyes, ears, speech, sensory function, seizures, intelligence, and other issues. The diagnosis is made based on signs of increased muscle tone, feeding difficulties, and developmental delays. Differential diagnoses need to be considered. Management aims to improve posture, reduce muscle tone, prevent contractures, and provide early
Perinatal asphyxia is caused by lack of oxygen or poor perfusion to organs in fetuses or newborns. It is defined by criteria like low umbilical cord pH, low Apgar scores, seizures or multiorgan dysfunction in newborns. It can cause neurological injuries like selective neuronal necrosis or periventricular leukomalacia. Management involves maintaining normal temperature, oxygenation, blood pressure, blood glucose and treating seizures. Outcomes are predicted by factors like lack of breathing at birth or severe hypoxic ischemic encephalopathy.
This document summarizes HIV infection in pediatric patients. It describes the natural history of the disease, including three patterns of progression. It discusses clinical manifestations, opportunistic infections like Pneumocystis pneumonia, and respiratory diseases seen in HIV-infected children. It also outlines the WHO clinical staging criteria for pediatric HIV/AIDS.
This document provides information on acute bacterial meningitis in pediatrics, including epidemiology, clinical features, diagnosis, treatment and other types of meningitis such as tuberculous, cryptococcal and pneumococcal meningitis. It describes the typical presentation of acute bacterial meningitis in children including fever, irritability, headache and altered mental status. Diagnosis is made through lumbar puncture and examination of cerebrospinal fluid. Treatment involves administration of antibiotics such as ceftriaxone intravenously for 10-14 days. Complications, steroid use, and other types of meningitis are also summarized.
Adhd Medication Shortage Uk - trinexpharmacy.comreignlana06
The UK is currently facing a Adhd Medication Shortage Uk, which has left many patients and their families grappling with uncertainty and frustration. ADHD, or Attention Deficit Hyperactivity Disorder, is a chronic condition that requires consistent medication to manage effectively. This shortage has highlighted the critical role these medications play in the daily lives of those affected by ADHD. Contact : +1 (747) 209 – 3649 E-mail : sales@trinexpharmacy.com
Here is the updated list of Top Best Ayurvedic medicine for Gas and Indigestion and those are Gas-O-Go Syp for Dyspepsia | Lavizyme Syrup for Acidity | Yumzyme Hepatoprotective Capsules etc
Integrating Ayurveda into Parkinson’s Management: A Holistic ApproachAyurveda ForAll
Explore the benefits of combining Ayurveda with conventional Parkinson's treatments. Learn how a holistic approach can manage symptoms, enhance well-being, and balance body energies. Discover the steps to safely integrate Ayurvedic practices into your Parkinson’s care plan, including expert guidance on diet, herbal remedies, and lifestyle modifications.
Rasamanikya is a excellent preparation in the field of Rasashastra, it is used in various Kushtha Roga, Shwasa, Vicharchika, Bhagandara, Vatarakta, and Phiranga Roga. In this article Preparation& Comparative analytical profile for both Formulationon i.e Rasamanikya prepared by Kushmanda swarasa & Churnodhaka Shodita Haratala. The study aims to provide insights into the comparative efficacy and analytical aspects of these formulations for enhanced therapeutic outcomes.
Histololgy of Female Reproductive System.pptxAyeshaZaid1
Dive into an in-depth exploration of the histological structure of female reproductive system with this comprehensive lecture. Presented by Dr. Ayesha Irfan, Assistant Professor of Anatomy, this presentation covers the Gross anatomy and functional histology of the female reproductive organs. Ideal for students, educators, and anyone interested in medical science, this lecture provides clear explanations, detailed diagrams, and valuable insights into female reproductive system. Enhance your knowledge and understanding of this essential aspect of human biology.
ABDOMINAL TRAUMA in pediatrics part one.drhasanrajab
Abdominal trauma in pediatrics refers to injuries or damage to the abdominal organs in children. It can occur due to various causes such as falls, motor vehicle accidents, sports-related injuries, and physical abuse. Children are more vulnerable to abdominal trauma due to their unique anatomical and physiological characteristics. Signs and symptoms include abdominal pain, tenderness, distension, vomiting, and signs of shock. Diagnosis involves physical examination, imaging studies, and laboratory tests. Management depends on the severity and may involve conservative treatment or surgical intervention. Prevention is crucial in reducing the incidence of abdominal trauma in children.
Cell Therapy Expansion and Challenges in Autoimmune DiseaseHealth Advances
There is increasing confidence that cell therapies will soon play a role in the treatment of autoimmune disorders, but the extent of this impact remains to be seen. Early readouts on autologous CAR-Ts in lupus are encouraging, but manufacturing and cost limitations are likely to restrict access to highly refractory patients. Allogeneic CAR-Ts have the potential to broaden access to earlier lines of treatment due to their inherent cost benefits, however they will need to demonstrate comparable or improved efficacy to established modalities.
In addition to infrastructure and capacity constraints, CAR-Ts face a very different risk-benefit dynamic in autoimmune compared to oncology, highlighting the need for tolerable therapies with low adverse event risk. CAR-NK and Treg-based therapies are also being developed in certain autoimmune disorders and may demonstrate favorable safety profiles. Several novel non-cell therapies such as bispecific antibodies, nanobodies, and RNAi drugs, may also offer future alternative competitive solutions with variable value propositions.
Widespread adoption of cell therapies will not only require strong efficacy and safety data, but also adapted pricing and access strategies. At oncology-based price points, CAR-Ts are unlikely to achieve broad market access in autoimmune disorders, with eligible patient populations that are potentially orders of magnitude greater than the number of currently addressable cancer patients. Developers have made strides towards reducing cell therapy COGS while improving manufacturing efficiency, but payors will inevitably restrict access until more sustainable pricing is achieved.
Despite these headwinds, industry leaders and investors remain confident that cell therapies are poised to address significant unmet need in patients suffering from autoimmune disorders. However, the extent of this impact on the treatment landscape remains to be seen, as the industry rapidly approaches an inflection point.
TEST BANK For Community Health Nursing A Canadian Perspective, 5th Edition by...Donc Test
TEST BANK For Community Health Nursing A Canadian Perspective, 5th Edition by Stamler, Verified Chapters 1 - 33, Complete Newest Version Community Health Nursing A Canadian Perspective, 5th Edition by Stamler, Verified Chapters 1 - 33, Complete Newest Version Community Health Nursing A Canadian Perspective, 5th Edition by Stamler Community Health Nursing A Canadian Perspective, 5th Edition TEST BANK by Stamler Test Bank For Community Health Nursing A Canadian Perspective, 5th Edition Pdf Chapters Download Test Bank For Community Health Nursing A Canadian Perspective, 5th Edition Pdf Download Stuvia Test Bank For Community Health Nursing A Canadian Perspective, 5th Edition Study Guide Test Bank For Community Health Nursing A Canadian Perspective, 5th Edition Ebook Download Stuvia Test Bank For Community Health Nursing A Canadian Perspective, 5th Edition Questions and Answers Quizlet Test Bank For Community Health Nursing A Canadian Perspective, 5th Edition Studocu Test Bank For Community Health Nursing A Canadian Perspective, 5th Edition Quizlet Test Bank For Community Health Nursing A Canadian Perspective, 5th Edition Stuvia Community Health Nursing A Canadian Perspective, 5th Edition Pdf Chapters Download Community Health Nursing A Canadian Perspective, 5th Edition Pdf Download Course Hero Community Health Nursing A Canadian Perspective, 5th Edition Answers Quizlet Community Health Nursing A Canadian Perspective, 5th Edition Ebook Download Course hero Community Health Nursing A Canadian Perspective, 5th Edition Questions and Answers Community Health Nursing A Canadian Perspective, 5th Edition Studocu Community Health Nursing A Canadian Perspective, 5th Edition Quizlet Community Health Nursing A Canadian Perspective, 5th Edition Stuvia Community Health Nursing A Canadian Perspective, 5th Edition Test Bank Pdf Chapters Download Community Health Nursing A Canadian Perspective, 5th Edition Test Bank Pdf Download Stuvia Community Health Nursing A Canadian Perspective, 5th Edition Test Bank Study Guide Questions and Answers Community Health Nursing A Canadian Perspective, 5th Edition Test Bank Ebook Download Stuvia Community Health Nursing A Canadian Perspective, 5th Edition Test Bank Questions Quizlet Community Health Nursing A Canadian Perspective, 5th Edition Test Bank Studocu Community Health Nursing A Canadian Perspective, 5th Edition Test Bank Quizlet Community Health Nursing A Canadian Perspective, 5th Edition Test Bank Stuvia
Basavarajeeyam is an important text for ayurvedic physician belonging to andhra pradehs. It is a popular compendium in various parts of our country as well as in andhra pradesh. The content of the text was presented in sanskrit and telugu language (Bilingual). One of the most famous book in ayurvedic pharmaceutics and therapeutics. This book contains 25 chapters called as prakaranas. Many rasaoushadis were explained, pioneer of dhatu druti, nadi pareeksha, mutra pareeksha etc. Belongs to the period of 15-16 century. New diseases like upadamsha, phiranga rogas are explained.
2. Respiratory distress in the neonate is a common
problem
and it can be a serious neonatal emergency. Respiratory
distress is said to be present when tachypnea (RR >60
per
min) is accompanied by chest retractions and or grunt. It
can be due to respiratory and non-respiratory
Causes Early recognition and prompt
treatment is essential to improve outcomes
3. Approach
Respiratory distress in a neonate can be recognized by
the presence of varying combinations of tachypnea
(RR >60/min), chest retractions, grunting, flaring of ala
enasi and cyanosis. The gestation, age at onset, severity
of distress and presence of associated clinical features help
in arriving at diagnosis. It should be noted that chest
retractions are mild or absent in respiratory distress due
to non-respiratory causes. if a term baby born to a mother
with meconium stained liquor develops respiratory
distress within the first 24 hr, the most likely cause is
meconium aspiration syndrome (MAS). A term baby with
uncomplicated birth developing tachypnea in the first few
hours of birth is likely to have transient tachypnea of
newborn. Presence of suprasternal recessions with or
without stridor indicates upper airway obstruction.
4. Pulmonary causes of respiratory distress
Cause Time of onset Remarks
Respiratory distress
syndrome
Meconium aspiration
syndrome
Pneumonia
Transient tachypnea of
newborn
First 6 hr of life
First few hr of life
Any age
First 6 hr after birth
Common in preterm
neonates
Common in term, post-
term and small for date
babies; history
of meconium stained liquor
Often bacterial
Tachypnea with minimal
distress; lasts for 48-72 hr
Persistent pulmonary
hypertension
Pneumothorax
Tracheoesophageal fistula,
diaphragmatic hernia,
lobar
emphysema
Any age
Any age
Any age
Severe distress; cyanosis
Sudden deterioration;
usually during assisted
ventilation
May show associated
malformations;
polyhydramnios in
esophageal atresia
6. Cardiac disease. Cardiac etiology for respiratory distress
should be suspected if a neonate with distress has cyanosis
or hepatomegaly. Congenital heart disease and
cardiomyopathies
or rhythm disorders can present as congestive
cardiac failure in the neonatal period. Transposition of
great vessels (TGV) and hypoplastic left heart syndrome
usually present on day one with progressive distress. Most
other cardiac conditions present after the first week of life.
A preterm neonate having a systolic murmur with
tachypnea
and hepatomegaly is likely to have patent ductus
arteriosus (PDA).
7. Neurological causes. Neonates with birth asphyxia,
cerebral
hemorrhage, or meningitis can present with tachypnea
and respiratory distress. These neonates are usually
lethargic with poor neonatal reflexes
8. Respiratory Distress Syndrome (RDS) or
Hyaline Membrane Disease (HMD)
RDS is common in preterm babies less than 34 weeks
of
gestation. The overall incidence is 10-15% but can be
as
high as 80% in neonates <28 weeks. In addition to
prematurity, asphyxia, acidosis, maternal diabetes and
cesarean section can increase the risk of RDS
9. Etiopathogenesis
In RDS, the basic abnormality is surfactant deficiency.
Surfactant is a lipoprotein containing phospholipids like
phosphatidylcholine and phosphatidylglycerol and
proteins. Surfactant is produced by type II alveolar cells
of lungs and helps reduce surface tension in the alveoli.
In the absence of surfactant, surface tension increases and
alveoli tend to collapse during expiration. During inspiration
more negative pressure is needed to keep alveoli
patent. There is inadequate oxygenation and increased
work of breathing. Hypoxernia and acidosis result in pulmonary
vasoconstriction and right to left shunting across
the forarnen ovale. This worsens the hypoxernia and the
neonate eventually goes into respiratory failure. Ischernic
damage to the alveoli causes transudation of proteins into
the alveoli that forms hyaline membrane. Surfactant production
starts around 20 weeks of life and peaks at 35 week
gestation. Therefore any neonate less than 35 week is prone
to develop RDS.
10. Clinical Features
Respiratory distress usually occurs within the first 6 hr of
life. Clinical features include tachypnea, retractions,
grunting, cyanosis and decreased air entry. Diagnosis can
be confirmed by chest X-ray. Radiological features include
reticulogranular pattern, ground glass opacity, low lung
volume, air bronchograrn and white out lungs
in severe disease.
11. Moderate to severe hyaline membrane disease. Note
homogenous opacification of lungs obscuring heart borders and
presence of air bronchogram (arrows)
12. Management
Neonates suspected to have RDS need to be cared for in
neonatal intensive care unit with IV fluids and oxygen.
Mild to moderate RDS can be managed with continuous
positive airway pressure (CPAP). CPAP is a non invasive
modality of support where a continuous distending
pressure (5-7 cm of water) is applied at nostril level to
keep the alveoli open in a spontaneously breathing baby
13. This is an excellent modality of respiratory
support which minimizes lung injury and other
complications
such as air leak and sepsis. Preterm babies
developing severe RDS often require mechanical
ventilation. Preterm babies are at risk of lung injury by
excessive pressure and high oxygen. High saturations of
oxygen (above 95%) can produce retinopathy of
prematurity
(ROP) which can blind the infant.
14. Since surfactant deficiency is the basis of RDS,
exogenous surfactant is recommended as the treatment
of choice in neonates with RDS. Surfactant is indicated in
all neonates with moderate to severe RDS. The route of
administration is intra tracheal. It can be given as a rescue
treatment (when RDS actually develops) or prophylactically
(all neonates less than 28 weeks irrespective of
presence or absence of RDS). Surfactant decreases duration and level of
support of ventilation in neonates and
therefore improves outcome. Many babies can be
INtubated, given SURfactant and rapidly Extubated
(lnSurE approach) to CPAP. This avoids the
need for mechanical ventilation in many neonates.
RDS has generally a good prognosis if managed
appropriately. Survival is as high as 90% in very low birth
weight babies (<1500 g). In the absence of ventilatory
support, most neonates with severe disease will die
16. Prevention of RDS
Administration of antenatal steroids to mothers in
preterm
labor ( <35 week) has been a major breakthrough in
management of preterm infants. Antenatal steroids
reduces RDS, intraventricular hemorrhage and
mortality
in preterm neonates
17. Benefits of administering antenatal
glucocortlcoids
Reduction in neonatal mortality by 40%
Reduction in respiratory distress by 50%
Reduction in intraventricular hemorrhage by 50%
Reduction in occurrence of patent ductus arteriosus,
necrotizing enterocolitis, hemodynamic instability
18. Pneumonia
Pneumonia is a common cause of respiratory distress in
both term and preterm babies and is caused by bacteria
such E. coli, S. aureus and K. pneumoniae. Neonatal
pneumonia may be due to aspiration or occasionally due
to viral or fungal infection. Though group B streptococcal
pneumonia is common in the West, it is uncommonly
reported in India.
19. Pneumonia
Pneumonia is a common cause of respiratory distress in
both term and preterm babies and is caused by bacteria
such E. coli, S. aureus and K. pneumoniae. Neonatal
pneumonia may be due to aspiration or occasionally due
to viral or fungal infection. Though group B streptococcal
pneumonia is common in the West, it is uncommonly
reported in India.
The neonate has features suggestive of sepsis in addition
to respiratory distress. Chest X-ray shows
pneumonia8.46), blood counts are raised and blood
culture may
be positive.
21. Treatment includes supportive care and
specific antibiotic therapy. Ampicillin or cloxacillin
with
gentamicin is usually used. If the pneumonia is due to
hospital acquired infection, antibiotics like
cephalosporins
with amikacin may have to be used.
22. Transient Tachypnea of Newborn (TTN)
Transient tachypnea of the newborn is a benign
selflimiting
disease occurring usually in term neonates and
is due to delayed clearance of lung fluid. These babies
have tachypnea with minimal or no respiratory
distress.
Chest X-ray may show hyperexpanded lung fields,
prominent vascular marking and prominent interlobar
fissure Oxygen treatment is often adequate.
Prognosis is excellent.
23. Transient tachypnea of newborn. Note hyperinflated lungs,
prominent bronchovascular markings and horizontal fissure (arrow
24. Surgical Problems
Tracheoesophageal fistula (TEF) should be suspected in
any neonate with excessive frothing. Diagnosis can be
confirmed by a plain X-ray with a red rubber catheter (not
infant feeding tube, it is soft and gets coiled up) inserted
in stomach; the catheter generally stops at 10th thoracic
vertebrae in presence of esophageal atresia. Presence of
gastric bubble suggest concomitant TEF.
Diaphragmatic hernia should be suspected in any
neonates who has severe respiratory distress and has a
scaphoid abdomen. This condition can be detected during
antenatal ultrasonography. Chest X-ray shows presence
of bowel loops in the thoracic cavity.
25. Bronchopulmonary Dysplasla (BPD)
CLD occurs because of barotrauma and oxygen toxicity
that causes damage to the alveolar cells, interstitium and
blood vessels. Inflammatory mediators are released and
there is increased permeability causing leakage of water
and protein. In later stages, there is fibrosis and cellular
hyperplasia. Severe lung damage leads to respiratory
failure. These babies continue to require prolonged oxygen
therapy or ventilatory support.
26. Pneumothorax
Presence of air in the pleural cavity (pneumothorax) is
most common in babies with meconium aspiration
syndrome and those being ventilated (Fig. 8.48).
Transillumination of the chest can help in diagnosis.
Needle aspiration or chest tube drainage is a life saving
procedure in this situation
27. Apnea
Apnea is defined as cessation of respiration for 20 seconds
with or without bradycardia and cyanosis or for shorter
periods if it is associated with cyanosis or bradycardia.
Apnea is a common problem in preterm neonates. It could
be central, obstructive or mixed.
Apnea of prematurity occurs in preterm neonates
between the second to fifth days of life and is because of
the immaturity of the developing brain. Central apnea can
also occur because of pathological causes like sepsis,
metabolic problems (hypoglycemia, hypocalcemia), temperature
instability, respiratory distress, anemia and
polycythemia. Obstructive apnea can occur because of
block to the airway by secretion or improper neck
positioning.
28. Treatment is supportive and involves correction of
underlying cause. Apnea of prematurity is treated with
aminophylline or caffeine. Prognosis is good in apnea
of
prematurity. In other cases it depends on the
underlying
29. Meconium Aspiratrion Syndrome (MAS)
Meconiurn staining of amniotic fluid (MSAF) occur in
10%-14% of pregnancies. Neonates born through MSAF
can aspirate the meconium into the lungs and develop
respiratory distress (meconium aspiration syndrome;
MAS). Aspirated meconium can block the large and small
airway causing areas of atelectasis and emphysema which
can progress to develop air leak syndromes like
pneumothorax.
Presence of atelectasis and emphysema can cause
ventilation perfusion mismatch in these babies that can
progress to respiratory failure. Meconium also induces
chemical pneumonitis.
30. Clinical Features and Course
MAS usually occurs in term or post term babies and small
for dates babies. Infants usually develops respiratory
distress in the first few hours of life that often
deteriorates
in subsequent 24-48 hr. If untreated, distress can progress
to respiratory failure. Complications include
pneumothorax,
other air leak syndromes (pneumopericardiurn,
pneumomediastinurn) and persistent pulmonary
hypertension.
Chest X-ray shows bilateral heterogeneous
opacities, areas of hyperexpansion and atelectesis and air
leak
32. Management
Clinical course in these babies can be complicated by
severe pulmonary hypertension. A good supportive care
in terms of maintenance of normal body temperature,
blood glucose and calcium levels, ensuring analgesia and
avoiding unnecessary fiddling pay good dividends.
Oxygenation and ventilation is maintained by judicious
use of oxygen and mechanical ventilation. With ventilatory
support, 60-70% neonates survive, but in the absence of
ventilatory support, mortality is high in severe disease
33. Persistent Pulmonary Hypertension (PPHN)
It is caused by a persistent elevation in pulmonary vascular
resistance resulting in right to left shunt across the
forarnen
ovale and/ or ductus. The disease is more common in term
and post-term babies and occurs as a result of persistent
hypoxia and acidosis. Hypoxia and hypercarbia cause
pulmonary vasoconstriction. This increases pulmonary
vascular pressure and results in right to left shunting
34. Common causes include asphyxia, respiratory distress
due to MAS, RDS, diaphragmatic hernia, etc. Primary
pulmonary hypertension can also occur because of an
abnormal pulmonary vasculature secondary to chronic
intrauterine hypoxia.
The neonate usually presents with severe respiratory
distress and cyanosis. It is often difficult to differentiate
PPHN from cyanotic congenital heart disease.
Echocardiography
helps in ruling out congenital heart disease
and may demonstrate right to left shunt across the forarnen
ovale. Ventilatory support is mandatory. Nitric oxide, a
selective pulmonary vasodilator is an effective therapy.